Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Calcitonin inhibits both osteoclast formation and bone resorption, and is a primary treatment for patients with hypercalcemia and increased bone turnover. However, the clinical utility of calcitonin is limited because patients become refractory to calcitonin after several days (the calcitonin "escap...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Takahashi, S, Goldring, S, Katz, M, Hilsenbeck, S, Williams, R, Roodman, G D
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1995
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7814611/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117634
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!